Key result
POSPOM score links to ~11% higher odds of 30-day mortality per point.
Why the study?
Does the Preoperative Score to Predict Postoperative Mortality (POSPOM) accurately predict 30-day postoperative mortality in a diverse US surgical population and across high-risk and racial/ethnic subgroups?
Cohort (n=17,262)
Yes
Does the Preoperative Score to Predict Postoperative Mortality (POSPOM) accurately predict 30-day postoperative mortality in a diverse US surgical population and across high-risk and racial/ethnic subgroups?
Answers are grounded in this paper and cite their sources.
While POSPOM demonstrates moderate discrimination (AUC 0.764) for 30-day postoperative mortality overall in a diverse US cohort, it provides poor risk stratification in high-risk surgical patients (AUC 0.583) and may underrepresent baseline mortality risk among high-risk Black patients, indicating a need for demographic recalibration before clinical implementation.
Background The Preoperative Score to Predict Postoperative Mortality (POSPOM), a point-based score using only preoperative variables, was developed and validated to predict in-hospital postoperative mortality in European surgical cohorts. Other widely used clinical risk tools perform differently across racial and socioeconomic groups. Although postoperative mortality has been studied in diverse US surgical populations, POSPOM performance across racial and ethnic subgroups remains insufficiently characterized. Objective This study aimed to evaluate POSPOM performance for 30-day postoperative mortality in a diverse US cohort and explore its performance for 1-year mortality among high-risk surgical patients and across racial and ethnic subgroups. Methods We performed a retrospective cohort study using the All of Us Research Program. Adults aged 18 to 91 years who underwent 1 of 21 POSPOM-eligible surgical procedures were included, and only each participant’s most recent eligible procedure was analyzed. POSPOM scores were calculated from age, procedure type, and 15 weighted comorbidities. The primary outcome was 30-day postoperative mortality, as incomplete discharge data precluded reliable assessment of in-hospital mortality; 1-year mortality was examined as an exploratory secondary outcome. Logistic regression estimated odds ratios (ORs) per 1-point increase in the POSPOM score, and discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). A high-risk subgroup (procedure points ≥14) was analyzed separately, and outcomes across racial and ethnic subgroups were explored descriptively. Given the small subgroup sizes and few events, subgroup analyses were interpreted cautiously. Results Among 17,262 patients, 12 (0.1%) died within 30 days and 45 (0.3%) within 1 year. For 30-day mortality, POSPOM yielded an AUC of 0.764, with higher odds of death per point (OR 1.112, 95% CI 1.040-1.190; P =.002). Discrimination was lower for 1-year mortality (AUC 0.638; OR 1.054, 95% CI 1.017-1.092; P =.004). In the high-risk subgroup (n=536; 30-day mortality 1.1%, 1-year mortality 2.1%), the 30-day AUC fell to 0.583, with no significant association (OR 0.942, 95% CI 0.812-1.092; P =.43). For 1-year mortality, the AUC was 0.692, with an inverse association (OR 0.882, 95% CI 0.781-0.998; P =.046). Descriptively, high-risk Black patients had higher 30-day mortality than White patients (2/61, 3.3% vs 4/348, 1.1%); no deaths were recorded among Asian, other-race, or Hispanic high-risk patients. Conclusions POSPOM demonstrated an AUC of 0.764 for 30-day mortality overall but provided limited risk stratification among high-risk surgical patients. Higher observed mortality among high-risk Black patients suggests the score may not fully capture baseline risk across racial groups, possibly reflecting structural and social factors outside its scope. As the 1-year and subgroup analyses were exploratory with few events, larger, adequately powered US studies are needed to evaluate POSPOM at its intended in-hospital end point, assess calibration across diverse populations, and inform recalibration before broader clinical use.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2026) conducted a cohort in Surgical patients undergoing POSPOM-eligible procedures (n=17,262). Preoperative Score to Predict Postoperative Mortality (POSPOM) per 1-point increase was evaluated on 30-day postoperative mortality (OR 1.112, 95% CI 1.040-1.190, p=0.002). POSPOM predicted 30-day postoperative mortality with an AUC of 0.764 and higher odds of death per point, though discrimination fell to 0.583 in high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: